Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aporphines | 15 | 2025 | 15 | 7.020 |
Why?
|
| Receptors, Dopamine D1 | 9 | 2025 | 46 | 4.600 |
Why?
|
| Structure-Activity Relationship | 25 | 2025 | 506 | 2.880 |
Why?
|
| Receptors, Serotonin | 5 | 2025 | 23 | 2.770 |
Why?
|
| Receptors, Dopamine | 4 | 2024 | 30 | 2.620 |
Why?
|
| Ligands | 18 | 2025 | 388 | 2.340 |
Why?
|
| Benzazepines | 4 | 2023 | 33 | 2.200 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 6 | 2016 | 15 | 1.800 |
Why?
|
| Molecular Structure | 18 | 2025 | 570 | 1.710 |
Why?
|
| Berberine | 6 | 2023 | 9 | 1.650 |
Why?
|
| Serotonin Antagonists | 3 | 2025 | 22 | 1.600 |
Why?
|
| Receptors, Dopamine D3 | 6 | 2025 | 17 | 1.530 |
Why?
|
| Diterpenes | 12 | 2012 | 97 | 1.430 |
Why?
|
| Dopamine Antagonists | 6 | 2023 | 48 | 1.320 |
Why?
|
| Dopamine Agonists | 3 | 2020 | 34 | 1.300 |
Why?
|
| Drug Discovery | 2 | 2025 | 108 | 1.060 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2025 | 1124 | 0.940 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2025 | 39 | 0.920 |
Why?
|
| Salvia | 6 | 2007 | 10 | 0.900 |
Why?
|
| Biological Products | 2 | 2024 | 91 | 0.890 |
Why?
|
| Alkaloids | 3 | 2025 | 46 | 0.840 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 59 | 0.790 |
Why?
|
| Amides | 1 | 2023 | 71 | 0.770 |
Why?
|
| Diterpenes, Clerodane | 11 | 2008 | 11 | 0.750 |
Why?
|
| Plants, Medicinal | 5 | 2006 | 57 | 0.720 |
Why?
|
| Xylenes | 1 | 2021 | 2 | 0.700 |
Why?
|
| Furans | 4 | 2007 | 40 | 0.680 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2021 | 22 | 0.680 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2020 | 3 | 0.640 |
Why?
|
| Azepines | 1 | 2020 | 22 | 0.640 |
Why?
|
| Stereoisomerism | 7 | 2025 | 169 | 0.560 |
Why?
|
| Receptors, Opioid, kappa | 7 | 2008 | 23 | 0.510 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 1019 | 0.500 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2016 | 7 | 0.500 |
Why?
|
| Amines | 1 | 2016 | 41 | 0.490 |
Why?
|
| Receptors, sigma | 1 | 2016 | 16 | 0.480 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1092 | 0.470 |
Why?
|
| Humans | 27 | 2025 | 43102 | 0.470 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2011 | 13 | 0.430 |
Why?
|
| Lamiaceae | 1 | 2012 | 3 | 0.380 |
Why?
|
| Receptors, Opioid, mu | 5 | 2008 | 52 | 0.380 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 65 | 0.360 |
Why?
|
| Animals | 18 | 2025 | 16992 | 0.360 |
Why?
|
| Cocaine | 3 | 2020 | 251 | 0.350 |
Why?
|
| Binding Sites | 5 | 2023 | 671 | 0.340 |
Why?
|
| Acetylcholinesterase | 1 | 2010 | 56 | 0.320 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2010 | 44 | 0.320 |
Why?
|
| Receptors, Opioid, delta | 3 | 2007 | 23 | 0.320 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 8 | 0.320 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2025 | 157 | 0.310 |
Why?
|
| Molecular Conformation | 4 | 2020 | 155 | 0.300 |
Why?
|
| Caco-2 Cells | 2 | 2022 | 64 | 0.270 |
Why?
|
| Extinction, Psychological | 2 | 2020 | 104 | 0.270 |
Why?
|
| Drug Design | 2 | 2024 | 186 | 0.260 |
Why?
|
| Piperazines | 2 | 2025 | 120 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 2 | 2016 | 102 | 0.240 |
Why?
|
| Pyrones | 1 | 2005 | 11 | 0.230 |
Why?
|
| Narcotic Antagonists | 1 | 2005 | 78 | 0.230 |
Why?
|
| Isoquinolines | 1 | 2025 | 55 | 0.220 |
Why?
|
| Algorithms | 2 | 2023 | 509 | 0.220 |
Why?
|
| Pyrimidines | 1 | 2025 | 139 | 0.210 |
Why?
|
| Analgesics, Opioid | 2 | 2006 | 252 | 0.210 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 180 | 0.200 |
Why?
|
| Protein Binding | 3 | 2023 | 1082 | 0.190 |
Why?
|
| Catechols | 1 | 2022 | 7 | 0.190 |
Why?
|
| Pregnanes | 1 | 2001 | 1 | 0.170 |
Why?
|
| Meliaceae | 1 | 2001 | 1 | 0.170 |
Why?
|
| Saponins | 1 | 2001 | 7 | 0.170 |
Why?
|
| Ergosterol | 1 | 2001 | 12 | 0.170 |
Why?
|
| Triterpenes | 1 | 2001 | 18 | 0.170 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2020 | 10 | 0.160 |
Why?
|
| Halogenation | 1 | 2020 | 19 | 0.160 |
Why?
|
| Proteins | 1 | 2023 | 382 | 0.160 |
Why?
|
| Hydrogen Bonding | 1 | 2020 | 144 | 0.160 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 83 | 0.150 |
Why?
|
| Cell Line | 3 | 2020 | 1410 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.150 |
Why?
|
| Reward | 2 | 2018 | 112 | 0.150 |
Why?
|
| Amino Acids | 1 | 2019 | 148 | 0.150 |
Why?
|
| Schistosoma mansoni | 1 | 2018 | 21 | 0.140 |
Why?
|
| Models, Chemical | 2 | 2010 | 204 | 0.140 |
Why?
|
| Kinetics | 2 | 2010 | 695 | 0.140 |
Why?
|
| Serotonin | 1 | 2018 | 123 | 0.140 |
Why?
|
| Self Administration | 1 | 2018 | 69 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 2676 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 830 | 0.130 |
Why?
|
| CHO Cells | 3 | 2007 | 123 | 0.130 |
Why?
|
| Cues | 1 | 2018 | 81 | 0.130 |
Why?
|
| Cricetinae | 3 | 2007 | 241 | 0.130 |
Why?
|
| Water | 1 | 2019 | 316 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2010 | 876 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 5 | 0.120 |
Why?
|
| Receptors, Opioid | 2 | 2006 | 40 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 83 | 0.120 |
Why?
|
| Rats | 5 | 2020 | 3735 | 0.120 |
Why?
|
| Thermodynamics | 2 | 2019 | 229 | 0.110 |
Why?
|
| Plant Leaves | 3 | 2005 | 136 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2019 | 188 | 0.110 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2005 | 84 | 0.100 |
Why?
|
| Radioligand Assay | 3 | 2008 | 65 | 0.090 |
Why?
|
| Male | 5 | 2025 | 23409 | 0.090 |
Why?
|
| HCT116 Cells | 1 | 2011 | 40 | 0.090 |
Why?
|
| Crystallography, X-Ray | 3 | 2007 | 280 | 0.080 |
Why?
|
| Hallucinogens | 3 | 2005 | 29 | 0.080 |
Why?
|
| Electrophorus | 1 | 2010 | 3 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2010 | 25 | 0.080 |
Why?
|
| Spectrophotometry | 1 | 2010 | 63 | 0.080 |
Why?
|
| Iodobenzenes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fluoroacetates | 1 | 2009 | 2 | 0.080 |
Why?
|
| Ketanserin | 1 | 2009 | 4 | 0.080 |
Why?
|
| Trifluoroacetic Acid | 1 | 2009 | 2 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 118 | 0.080 |
Why?
|
| Appetite Depressants | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cyclization | 1 | 2009 | 50 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 423 | 0.070 |
Why?
|
| Cricetulus | 2 | 2007 | 82 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 99 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 223 | 0.070 |
Why?
|
| Cattle | 1 | 2010 | 498 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 97 | 0.070 |
Why?
|
| Arrestins | 1 | 2008 | 28 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2010 | 408 | 0.070 |
Why?
|
| Carbon | 1 | 2009 | 128 | 0.070 |
Why?
|
| Mass Spectrometry | 3 | 2008 | 280 | 0.070 |
Why?
|
| Arrestin | 1 | 2006 | 8 | 0.060 |
Why?
|
| Calcium | 1 | 2009 | 491 | 0.060 |
Why?
|
| Sapogenins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Endocytosis | 1 | 2006 | 118 | 0.060 |
Why?
|
| Dioscorea | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mice | 3 | 2018 | 6644 | 0.060 |
Why?
|
| Steroids | 1 | 2005 | 45 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 184 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 592 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 465 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 1001 | 0.050 |
Why?
|
| Euphorbiaceae | 1 | 2001 | 2 | 0.040 |
Why?
|
| Chromatography | 1 | 2001 | 17 | 0.040 |
Why?
|
| Plant Stems | 1 | 2001 | 12 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2001 | 31 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 50 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 2001 | 56 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2001 | 104 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 108 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2020 | 67 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 41 | 0.040 |
Why?
|
| Schistosomiasis | 1 | 2018 | 19 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 93 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 373 | 0.030 |
Why?
|
| Locomotion | 1 | 2018 | 105 | 0.030 |
Why?
|
| Fluorenes | 1 | 2016 | 26 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 234 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2005 | 139 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2008 | 301 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1766 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1596 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2006 | 26 | 0.020 |
Why?
|
| Morphine | 1 | 2006 | 69 | 0.020 |
Why?
|
| Amylases | 1 | 2005 | 3 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 30 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 12 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 67 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2005 | 27 | 0.010 |
Why?
|
| Narcotics | 1 | 2005 | 29 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 296 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2005 | 28 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 71 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 532 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 83 | 0.010 |
Why?
|
| Deuterium | 1 | 2004 | 11 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 19 | 0.010 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 31 | 0.010 |
Why?
|
| Eating | 1 | 2005 | 167 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 131 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 429 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 258 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 611 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2004 | 182 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 389 | 0.010 |
Why?
|
| Female | 2 | 2018 | 24698 | 0.010 |
Why?
|
| Jamaica | 1 | 2001 | 11 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 1081 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2004 | 302 | 0.010 |
Why?
|
| Methylation | 1 | 2001 | 119 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1857 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 1472 | 0.010 |
Why?
|